All In MedTech

Device Trial Radar · NCT02587403

A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair

A Randomized, Prospective Study Comparing Fortiva™ Porcine Dermis vs. Strattice™ Reconstructive Tissue Matrix in Patients Undergoing Complex Open Primary Ventral Hernia Repair

Last checked: Nov 20, 2026Latest source record: Dec 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

Dec 2, 2015

Primary completion

Sep 19, 2023

Study completion Sep 19, 2023

Sponsor

Lead sponsor
RTI SurgicalNot on our public-company list
Sponsor type
Industry
First posted
Oct 27, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to compare the effectiveness of Fortiva Porcine Dermis versus Strattice Reconstructive Tissue Matrix for the underlay reinforcement of complex ventral hernia repair and assess post-operative complication rates, long term hernia recurrence rates.

Conditions

  • Ventral Hernia

Interventions

  • Fortiva™ Porcine DermisDevice

    Fortiva Porcine Dermis implantation during repair of complex ventral hernia

  • Strattice™ Reconstructive Tissue MatrixDevice

    Strattice tissue matrix implanted during repair of complex ventral hernia

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Proportion of Patients Who Experience a True Hernia RecurrenceTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Washington University

    St Louis, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.